Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.60 -0.07 (-2.62%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kiora Pharmaceuticals (KPRX) Receivables - Accured (2015 - 2016)

Updated

Kiora Pharmaceuticals' Receivables - Accured was $89,825 in Q4 2016, up 0.9% from $88,995 a year earlier and up 0.2% from the prior quarter.

Analysis

Kiora Pharmaceuticals (KPRX) Receivables - Accured (2015 - 2016) Analysis & Trends

  • In earlier years, Receivables - Accured was $88,995 in FY2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables - Accured (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Kiora Pharmaceuticals 16.49 Mn 16.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 89,825.00
Sep 30, 2016 89,616.00
Dec 31, 2015 88,995.00
API Access

Kiora Pharmaceuticals Receivables - Accured API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-accured&ticker=KPRX&period=max&api_key=YOUR_API_KEY